Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid

Journal of Medicinal Chemistry

Volumn 39, Issue 18, 1996, Pages 3556-3563

  Beard, Richard L ^a   Colon, Diana F ^a   Song, Tae K ^a   Davies, Peter J A ^c   Kochhar, Devendra M ^b   Chandraratna, Roshantha A S ^a  

^a ALLERGAN INC   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RETINOIC ACID; RETINOIC ACID DERIVATIVE; RETINOID X RECEPTOR; SULFIDE; SULFONE DERIVATIVE; SULFOXIDE;

AGONIST; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HL 60; CHONDROGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; TERATOGENICITY; TRANSACTIVATION;

ANIMALS; CARTILAGE; CELL LINE; HL-60 CELLS; HUMANS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFIDES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; TRETINOIN;

EID: 0029795523     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960386h     Document Type: Article

References (42)

1. Reviews: (a) The Retinoids; Sporn, M. B., Roberts, A. B., Goodman, D. S., Eds.; Academic Press: Orlando, 1984.
2. (b) Chemistry and Biology of Synthetic Retinoids; Dawson, M. I., Okamura, W. H., Eds.; CRC Press: Boca Raton, FL, 1990.
3. (c) The Retinoids: Biology, Chemistry, and Medicine; Sporn, M. B., Roberts, A. B., Goodman, D. S., Eds.; Raven Press: New York, 1994.
4. Review: Retinoids: Present and Future. Proceedings of a Sympisium Held at the 18th World Congress of Dermatology; Shalita, A. R., Fritsch, P. O., Eds.; supplement to J. Am. Acad. Dermatol. 1992, 27 (6), part 2.
5. Reviews: (a) Reference 1a, pp 209-286.
6. (b) Tallman, M. S.; Wiernik, P. H. Retinoids in Cancer Treatment. J. Clin. Pharmacol. 1992, 32, 868-888.
7. Vinienti, M. P.; Clark, I. M.; Brinkerhoff, C. E. Using Inhibitors of Metalloproteinases to Treat Arthritis. Arthritis Rheumatoidism 1994, 37, 1115-1126.
8. Rottman, J. N.; Widom, R. L.; Nadal-Ginard, B.; Mahdavi, V.; Karathanansis, S. K. A Retinoic Acid-Responsive Element in the Apolipoprotein AI Gene Distinguishes Between Two Different Retinoic Acid Response Pathways. Mol. Cell. Biol. 1991, 3814-3820.
9. Yang, Y.; Vacchio, M. S.; Ashwell, J. D. 9-cis-Retinoic Acid Inhibits Activation-Driven T-Cell Apoptosis: Implications for Retinoid X Receptor Involvement in Thymocyte Development. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6170-6174.
10. Mangelsdorf, D. J.; Umesono, K.; Evans, R. M. The Retinoid Receptors. In ref 1c, pp 319-349.
11. (a) Petkovich, M.; Brand, N. J.; Krust, A.; Chambon, P. A Human Retinoic Acid Receptor Which Belongs to the Family of Nuclear Receptors. Nature 1987, 330, 444-450.
12. (b) Giguère, V.; Ong, E. S.; Segui, P.; Evans, R M. Identification of a Receptor for the Morphogen Retinoic Acid. Nature 1987, 330, 624-629.
13. (c) Brand, N.; Petkovich, M.; Krust, A.; Chambon, P.; de The, H.; Marchio, A.; Dejean, A. Identification of a Second Human Retinoic Acid Receptor. Nature 1988, 332, 850-853.
14. (d) Krust, A.; Kastner, P.; Petkovich, M.; Zelent, A.; Chambon, P. A Third Human Retinoic Acid Receptor, hRARγ. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 5310-5314.
15. (a) Mangelsdorf, D. J.; Ong, E. S.; Dyck, J. A.; Evans, R. M. Nuclear Receptor That Identifies a Novel Retinoic Acid Response Pathway. Nature 1990, 345, 224-229.
16. (b) Mangelsdorf, D. J.; Borgmeyer, U.; Heyman, R. A.; Zhou, J. Y.; Ong, E. S.; Oro, A. E.; Kakizuka, A.; Evans, R. M. Characterization of Three RXR Genes That Mediate the Action of 9-cis Retinoic Acid. Gen. Dev. 1992, 6, 329-344.
17. (a) Heyman, R. A.; Mangelsdorf, D. J.; Dyck, J. A.; Stein, R. B.; Eichele, G.; Evans, R. M.; Thaller, C. 9-Cis Retinoic Acid is a High Affinity Ligand for the Retinoid X Receptor. Cell 1992, 68, 397-406.
18. α. Nature 1992, 355, 359-361.
19. β: A Coregulator That Enhances Binding of Retinoic Acid, Thyroid Hormone, and Vitamin D Receptors to Their Cognate Response Elements. Cell 1991, 67, 1251-1266.
20. (b) Zhang, X.-k.; Hoffman, B.; Tran, P. B.-V.; Graupner, G.; Pfahl, M. Retinoid X Receptor is an Auxilliary Protein for Thyroid Hormone and Retinoic Acid Receptors. Nature 1992, 355, 441-446.
21. (c) Leid, M.; Kastner, P.; Lyons, R.; Nakshari, H.; Saunders, M.; Zacharewski, T.; Chen, J.-Y.; Staub, A.; Garnier, J.-M.; Mader, S.; Chambon, P. Purification, Cloning and RXR Identity of the HeLa Cell Factor With Which RAR or TR Heterodimerizes to Bind Target Sequences Efficiently. Cell 1992, 68, 377-395.
22. (d) Kleiwer, S. A.; Umesono, K.; Mangelsdorf, D. J.; Evans, R. M. Retinoid X Receptor Interacts With Nuclear Receptors in Retinoic Acid, Thyroid Hormone, and Vitamin D3 Signaling. Nature 1992, 355, 446-449.
23. α, A Promiscuous Partner of Retinoic Acid and Thyroid Hormone Receptors. EMBO J. 1992, 11, 1409-1418.
24. β) Heterodimerization Provides a Mechanism for Combinatorial Diversity in the Regulation of Retinoic Acid and Thyroid Hormone Responsive Genes, EMBO J. 1992, 11, 1419-1435.
25. Roy, B.; Taneja, R.; Chambon, P. Synergistic Activation of Retinoic Acid (RA)-Responsive Genes and Induction of Embryonal Carcinoma Cell Differentiation by an RA Receptor α (RARα)-, RARβ-, or RARγ-Selctive Ligand in Combination with a Retinoid X Receptor-Specific Ligand. Mol. Cell. Biol. 1995, 15, 6481-6487.
26. Zhang, X.-K.; Lehmann, J.; Hoffmann, B.; Dawson, M. I.; Cameron, J.; Graupner, G.; Hermann, T.; Tran, P.; Pfahl, M. Homodimer Formation of Retinoid X Receptor by 9-cis-Retinoic Acid. Nature 1992, 358, 587-591.
27. (a) Beard, R. L.; Gil, D. W.; Marier, D. K.; Henry, E.; Colon, D. F.; Gillett, S. J.; Arefieg, T.; Breen, T. S.; Krauss, H.; Davies, P. J. A.; Chandraratna, R. A. S. Structural Basis for the Differential RXR & RAR Activity of Stilbene Retinoid Analogs. Bioorg. Med. Chem. Lett. 1994, 4, 1447-1452.
28. 3H]-9-cis-Retinoic acid and Its Application for Identifying Retinoids with Unusual Binding Properties. J. Med. Chem. 1994, 37, 408-414.
29. (a) Beard, R. L.; Chandraratna, R. A. S.; Colon, D. F.; Gillett, S. J.; Henry, E.; Marier, D. K.; Song, T.; Denys, L.; Garst, M. E.; Arefieg, T.; Klein, E. S.; Gil, D. W.; Wheeler, L.; Kochhar, D. M.; Davies, P. J. A. Synthesis and Structure-Activity Relationships of Stilbene Retinoid Analogs Substituted with Heteroaromatic Carboxylic Acids. J. Med. Chem. 1995, 38, 2820-2829.
30. (b) Beard, R. L.; Colon, D. F.; Klein, E. S.; Vorse, K. A.; Chandraratna, R. A. S. Differential RXR and RAR Activity of Stilbene Retinoid Analogs Bearing Thiazole and Imidazole Carboxylic Acids. Bioorg. Med. Chem Lett. 1995, 5, 2729-2734.
31. (a) Lehmann, J. M.; Jong, L.; Fanjul, A.; Cameron, J. F.; Lu, X. P.; Haefner, P.; Dawson, M. I.; Pfahl, M. Retinoids Selective for Retinoid X Receptor Response Pathways. Science 1992, 258, 1944-1946.
32. (b) Boehm, M. F.; Zhang, L.; Badea, B. A.; White, S. K.; Mais, D. E.; Berger, E.; Suto, C. M.; Goldman, M. E.; Heyman, R. A. Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids. J. Med. Chem. 1994, 37, 2930-2941.
33. (c) Boehm, M. F.; Zhang, L.; Zhi, L.; McClurg, M. R.; Berger, E.; Wagoner, M.; Mais, D. E.; Suto, C. M.; Davies, P. J. A.; Heyman, R. A.; Nadzan, A. M. Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells. J. Med. Chem. 1995, 38, 3146-3155.
34. Jong, L.; Lehmann, J. M.; Hobbs, P. D.; Harlev, E.; Huffman, J. C.; Pfahl, M.; Dawson, M. I. Conformational Effects on Retinoid Receptor Selectivity. 1. Effect of 9-Double Bond Geometry on Retinoid X Receptor Activity. J. Med. Chem. 1993, 36, 2605-2613.
35. Janssen, B.; Wuest, H.-H. (BASF A.-G.) Diphenylheteroalkyl-derivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika. (Diphenylheteroalkyl derivatives, their preparation and formulation as medicines and cosmetics.) European Patent Application EP 0 386 452 A1, Sept. 12, 1990.
36. 18 for the synthesis of 5,6,7,8-tetrahydro-5,5,8,8-tetramethylnaphthalene-2-thiol (7).
37. Umesono, K.; Giguere, V.; Glass, C. K.; Rosenfeld, M. G.; Evans, R. M. Retinoic Acid and Thyroid Hormone Induce Gene Expression Through a Common Responsive Element. Nature 1988, 336, 262-265.
38. Berger, T. S.; Parandoosh, Z.; Perry, B. W.; Stein, R. B. Interaction of Glucocorticoid Analogues With the Human Glucocorticoid Receptor. J. Steroid Biochem. Mol. Biol. 1992, 41, 733-738.
39. Davies, P. J. A.; Martaugh, M. P.; Moore, W. T.; Johnson, G. S.; Lucas, D. Retinoic Acid-induced Expresion of Tissue Transglutaminase in Human Promyelocytic Leukemia (HL-60) Cells. J. Biol. Chem. 1985, 260, 5166-5174.
40. Kistler, A. Limb Bud Cell Cultures for Estimating the Teratogenic Potential of Compounds: Validation of the Test System With Retinoids. Arch. Toxicol. 1987, 60, 403-414.
41. (a) Kochhar, D. M.; Kraft, J. C.; Nau, H. Teratogenicity and Disposition of Various Retinoids In vivo and In vitro. In Pharmacokinetics in Teratogenesis; Nau, H.; Scott, W. J., Eds.; CRC Press: Boca Raton, FL, 1987.
42. (b) Kochhar, D. M.; Jiang, H.; Penner, J. D.; Beard, R. L.; Chanadraratna, R. A. S. Differential Teratogenic Response of Mouse Embryos to Receptor Selective Analogs of Retinoic Acid. Chem. Biol. Inteact. 1996, 100, 1-12.